Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027
The infection surveillance solutions market is anticipated to grow from an estimated USD 577 million in 2022 to USD 1,100 million in 2027, at a CAGR of 13.8% during the forecast period. The market has a promising growth potential due to increased demand the increasing prevalence of hospital-acquired infections, increasing surgical procedures, and rising healthcare expenditure among other factors. However, the Shortage of skilled healthcare IT professionals and Data security concerns are expected to limit the growth of this market to a certain extent.
“Training & Consulting Services: The fastest-growing segment of the infection surveillance services market, by type“
Training & consulting services are expected to witness the fastest growth in the infection surveillance services market during the forecast. Training and consulting services increase healthcare providers’ awareness of the latest infection surveillance solutions available in the market. Most large and mid-size companies actively provide technical assistance to hospitals, independent laboratories, and physician office laboratories that use infection surveillance software. Factors such as the increasing importance of value-based care, technological advancements, and growing consolidation in healthcare are driving the market for consulting services.
“The large hospitals is anticipated to be the largest infection surveillance solutions market for hospitals, by type, during the forecast period”
Based on type (the number of beds), hospitals are segmented into large (>450 beds), medium-sized (250–449 beds), and small (<249 beds) hospitals. The large hospitals segment accounted for the largest share of the infection surveillance solutions market for hospitals. The rising number of private hospitals in China and other developing countries is expected to drive the demand for technologically advanced HCIT solutions deployed in ICUs and other departments of hospitals. Furthermore, the complexity of managing HAIs rises with the size of hospitals, as more patients need to be monitored continuously; this is the primary reason for the large share of this end-user segment.
“Europe accounted for the second-largest share in the infection surveillance solutions market during the forecast period”
Europe accounted for the second-largest share of the infection surveillance solutions market during the forecast period. Growth in the European market can be attributed to the increasing adoption of HCIT solutions, the increasing incidence of HAIs, the increasing number of surgeries, and the rising geriatric population. The increasing need to improve patient outcomes has contributed to the adoption of infection surveillance solutions across the region. Several policies and guidelines have been implemented in Europe as infection prevention strategies for hospitals and long-term care facilities which are propelling the demand for infection surveillance solutions in the region.
Break of primary participants was as mentioned below:
The key players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US).
Research Coverage:
The report analyzes the infection surveillance solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service, end user, and region. The report also includes a product portfolio matrix of various infection surveillance solutions products & services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
“Training & Consulting Services: The fastest-growing segment of the infection surveillance services market, by type“
Training & consulting services are expected to witness the fastest growth in the infection surveillance services market during the forecast. Training and consulting services increase healthcare providers’ awareness of the latest infection surveillance solutions available in the market. Most large and mid-size companies actively provide technical assistance to hospitals, independent laboratories, and physician office laboratories that use infection surveillance software. Factors such as the increasing importance of value-based care, technological advancements, and growing consolidation in healthcare are driving the market for consulting services.
“The large hospitals is anticipated to be the largest infection surveillance solutions market for hospitals, by type, during the forecast period”
Based on type (the number of beds), hospitals are segmented into large (>450 beds), medium-sized (250–449 beds), and small (<249 beds) hospitals. The large hospitals segment accounted for the largest share of the infection surveillance solutions market for hospitals. The rising number of private hospitals in China and other developing countries is expected to drive the demand for technologically advanced HCIT solutions deployed in ICUs and other departments of hospitals. Furthermore, the complexity of managing HAIs rises with the size of hospitals, as more patients need to be monitored continuously; this is the primary reason for the large share of this end-user segment.
“Europe accounted for the second-largest share in the infection surveillance solutions market during the forecast period”
Europe accounted for the second-largest share of the infection surveillance solutions market during the forecast period. Growth in the European market can be attributed to the increasing adoption of HCIT solutions, the increasing incidence of HAIs, the increasing number of surgeries, and the rising geriatric population. The increasing need to improve patient outcomes has contributed to the adoption of infection surveillance solutions across the region. Several policies and guidelines have been implemented in Europe as infection prevention strategies for hospitals and long-term care facilities which are propelling the demand for infection surveillance solutions in the region.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–40%, Tier 2–35%, and Tier 3–25%
- By Designation – C-level–35%, Director-level–25%, Others–40%
- By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
The key players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US).
Research Coverage:
The report analyzes the infection surveillance solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service, end user, and region. The report also includes a product portfolio matrix of various infection surveillance solutions products & services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection surveillance solutions market. The report analyzes this market by product & service and end user.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection surveillance solutions market
- Market Development: Comprehensive information on the lucrative emerging markets by products & services and end user
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global infection surveillance solutions market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global infection surveillance solutions market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SEGMENTATION
FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Key insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 9 CAGR PROJECTIONS
FIGURE 10 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION APPROACH
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET
3 EXECUTIVE SUMMARY
FIGURE 12 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 16 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT, 2021
4 PREMIUM INSIGHTS
4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW
FIGURE 17 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY END USER AND COUNTRY
FIGURE 18 HOSPITALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021
4.3 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST REVENUE GROWTH FROM 2022 TO 2027
4.4 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2020–2027)
FIGURE 20 NORTH AMERICA TO DOMINATE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING FORECAST PERIOD
4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing prevalence of hospital-acquired infections
5.2.1.2 Increasing adoption of antimicrobial stewardship programs
5.2.1.3 Increasing number of surgeries
TABLE 4 US: PERCENTAGE INCREASE IN SURGICAL VOLUMES
5.2.1.4 Growing geriatric population and increasing incidence of chronic diseases
5.2.1.5 Growing investments to improve healthcare systems
5.2.2 MARKET RESTRAINTS
5.2.2.1 High cost of deployment for small healthcare organizations
TABLE 5 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2021
5.2.2.2 Reluctance among medical professionals to adopt advanced healthcare IT solutions
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing consolidation in healthcare industry
5.2.3.2 Cloud-based software solutions
5.2.3.3 Emerging markets
5.2.4 MARKET CHALLENGES
5.2.4.1 Shortage of skilled healthcare IT professionals
5.2.4.2 Data security concerns
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 SHIFT TOWARD WEB-BASED SOLUTIONS
6.2.2 AI-POWERED SURVEILLANCE SOFTWARE
6.2.3 SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES
6.2.4 INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS
6.3 REGULATORY ANALYSIS
6.3.1 NORTH AMERICA
TABLE 6 NORTH AMERICA: REGULATIONS AND LAWS
6.3.2 EUROPE
TABLE 7 EUROPE: REGULATIONS AND LAWS
6.3.3 ASIA
TABLE 8 ASIA: REGULATIONS AND LAWS
6.3.4 MIDDLE EAST & AFRICA
TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS AND LAWS
6.3.5 LATIN AMERICA
TABLE 10 LATIN AMERICA: REGULATIONS AND LAWS
TABLE 11 KEY GLOBAL REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS
6.4 TECHNOLOGY ANALYSIS
6.4.1 CLOUD COMPUTING TECHNOLOGY
6.4.2 ARTIFICIAL INTELLIGENCE
TABLE 12 AI IN HEALTHCARE MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 13 AI IN HEALTHCARE MARKET, BY REGION, 2021–2027 (USD MILLION)
6.4.3 BLUETOOTH LOW-ENERGY SENSORS
6.5 ECOSYSTEM ANALYSIS
FIGURE 22 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS
FIGURE 23 INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
6.6 PATENT ANALYSIS
6.6.1 PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2012–JANUARY 2023)
6.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012– JANUARY 2023)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012–JANUARY 2023)
TABLE 14 INFECTION SURVEILLANCE SOLUTIONS: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2022
6.7 IMPACT OF RECESSION
7 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
7.2 SOFTWARE
TABLE 16 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 ON-PREMISE SOFTWARE
7.2.1.1 Data protection and in-house access to HCIT solutions to drive market
TABLE 18 ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 19 ON-PREMISE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 WEB-BASED SOFTWARE
7.2.2.1 Increasing demand for data centralization and cost-benefits of solutions to drive adoption
TABLE 20 WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 21 WEB-BASED SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SERVICES
TABLE 22 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 23 INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 PRODUCT SUPPORT & MAINTENANCE SERVICES
7.3.1.1 Rising reliance on outsourcing HCIT support to boost demand
TABLE 24 PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 TRAINING & CONSULTING SERVICES
7.3.2.1 Need to develop IT infrastructure and demand for expert assistance to offer growth opportunities
TABLE 25 TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 IMPLEMENTATION SERVICES
7.3.3.1 Focus on ensuring regulatory compliance among end users to boost service sector growth
TABLE 26 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
TABLE 28 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 LARGE HOSPITALS
8.2.1.1 Growing need to deploy cloud-based solutions to drive growth
TABLE 30 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 MEDIUM-SIZED HOSPITALS
8.2.2.1 Increasing demand for more specialized and advanced care to boost market
TABLE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.3 SMALL HOSPITALS
8.2.3.1 Need to decrease operational costs and growing competition to support adoption
TABLE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 LONG-TERM CARE FACILITIES
TABLE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.1 NURSING HOMES
8.3.1.1 Growing geriatric population to favor end-user growth
TABLE 35 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.2 SKILLED NURSING FACILITIES
8.3.2.1 Advancements in HCIT solutions to favor adoption in SNFs
TABLE 36 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.3 ASSISTED LIVING FACILITIES
8.3.3.1 ALFs to show significant growth alongside rising geriatric population
TABLE 37 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 OTHER END USERS
TABLE 38 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2020–2027)
TABLE 39 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
FIGURE 28 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
TABLE 40 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.2.2 US
9.2.2.1 Advanced medical infrastructure and increasing healthcare expenditure to drive market growth
TABLE 47 US: KEY MACROINDICATORS
TABLE 48 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 49 US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 52 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Rising adoption of advanced HCIT solutions to propel market growth
TABLE 54 CANADA: KEY MACROINDICATORS
TABLE 55 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 59 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
TABLE 61 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 66 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Germany to hold largest share of European market
TABLE 68 GERMANY: KEY MACROINDICATORS
TABLE 69 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 73 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 High healthcare spending and favorable government initiatives to drive market growth in France
TABLE 75 FRANCE: KEY MACROINDICATORS
TABLE 76 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 80 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.4 UK
9.3.4.1 Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK
TABLE 82 UK: KEY MACROINDICATORS
TABLE 83 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 84 UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 87 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Increasing adoption of eHealth technologies to propel market growth in Italy
TABLE 89 ITALY: KEY MACROINDICATORS
TABLE 90 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 91 ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 94 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Emphasis on infrastructural improvement and rising disease prevalence to contribute to growth
TABLE 96 SPAIN: KEY MACROINDICATORS
TABLE 97 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 98 SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 101 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.7 SWITZERLAND
9.3.7.1 Increasing demand for healthcare services and growing healthcare awareness to augment market
TABLE 103 SWITZERLAND: KEY MACROINDICATORS
TABLE 104 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 105 SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 108 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.8 NETHERLANDS
9.3.8.1 Increasing healthcare initiatives to favor demand growth
TABLE 110 NETHERLANDS: KEY MACROINDICATORS
TABLE 111 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 112 NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 115 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.9 REST OF EUROPE
TABLE 117 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 118 ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 121 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
FIGURE 29 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
TABLE 123 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 124 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 128 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Japan to dominate APAC market over forecast period
TABLE 130 JAPAN: KEY MACROINDICATORS
TABLE 131 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 135 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Healthcare infrastructure improvements in China to contribute to market growth
TABLE 137 CHINA: KEY MACROINDICATORS
TABLE 138 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 139 CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 142 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing demand for HCIT solutions to support market growth
TABLE 144 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 145 INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 148 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.5 AUSTRALIA AND NEW ZEALAND
9.4.5.1 Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ
TABLE 150 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 151 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 154 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Increasing medical tourism to boost market
TABLE 156 SOUTH KOREA: KEY MACROINDICATORS
TABLE 157 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 158 SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 161 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 163 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 164 ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 167 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 FAVORABLE HCIT INITIATIVES TO DRIVE MARKET GROWTH
9.5.2 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
TABLE 169 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH
9.6.2 MIDDLE EAST AND AFRICA: IMPACT OF ECONOMIC RECESSION
TABLE 175 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
10.3 ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS
10.4 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS
10.5 MARKET SHARE ANALYSIS
FIGURE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET: MARKET SHARE ANALYSIS, 2021
10.6 COMPETITIVE BENCHMARKING
TABLE 181 COMPANY FOOTPRINT ANALYSIS
TABLE 182 PRODUCT & SERVICE FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 183 END-USER FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 184 REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES)
10.7 COMPANY EVALUATION QUADRANT, 2021
10.7.1 STARS
10.7.2 PERVASIVE PLAYERS
10.7.3 EMERGING LEADERS
10.7.4 PARTICIPANTS
FIGURE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2021
10.8 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
10.8.1 PROGRESSIVE COMPANIES
10.8.2 DYNAMIC COMPANIES
10.8.3 RESPONSIVE COMPANIES
10.8.4 STARTING BLOCKS
FIGURE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS
TABLE 185 INFECTION SURVEILLANCE SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS, 2020–2022
10.9.2 DEALS
TABLE 186 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEALS, 2020–2022
10.9.3 OTHER DEVELOPMENTS
TABLE 187 INFECTION SURVEILLANCE SOLUTIONS MARKET: OTHER DEVELOPMENTS, 2020–2022
11 COMPANY PROFILES
(Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 BECTON, DICKINSON AND COMPANY
TABLE 188 BD: COMPANY OVERVIEW
FIGURE 34 BD: COMPANY SNAPSHOT, 2022
TABLE 189 BD: PRODUCTS & SERVICES OFFERED
TABLE 190 BD: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 191 BD: DEALS
11.1.2 CERNER CORPORATION
TABLE 192 CERNER CORPORATION: COMPANY OVERVIEW
FIGURE 35 CERNER CORPORATION: COMPANY SNAPSHOT, 2021
TABLE 193 CERNER CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 194 CERNER CORPORATION: DEALS
11.1.3 PREMIER, INC.
TABLE 195 PREMIER, INC.: COMPANY OVERVIEW
FIGURE 36 PREMIER, INC.: COMPANY SNAPSHOT, 2022
TABLE 196 PREMIER, INC.: PRODUCTS & SERVICES OFFERED
TABLE 197 PREMIER, INC.: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 198 PREMIER, INC.: DEALS
11.1.4 BAXTER INTERNATIONAL INC.
TABLE 199 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW
FIGURE 37 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT, 2021
TABLE 200 BAXTER INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
11.1.5 WOLTERS KLUWER N.V.
TABLE 201 WOLTERS KLUWER N.V.: COMPANY OVERVIEW
FIGURE 38 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT, 2021
TABLE 202 WOLTERS KLUWER N.V.: PRODUCTS & SERVICES OFFERED
TABLE 203 WOLTERS KLUWER N.V.: LAUNCHES/ENHANCEMENTS
TABLE 204 WOLTERS KLUWER N.V.: OTHERS
11.1.6 MERATIVE
TABLE 205 MERATIVE: COMPANY OVERVIEW
TABLE 206 MERATIVE: PRODUCTS & SERVICES OFFERED
TABLE 207 MERATIVE: OTHERS
11.1.7 ECOLAB
TABLE 208 ECOLAB: COMPANY OVERVIEW
FIGURE 39 ECOLAB: COMPANY SNAPSHOT, 2021
TABLE 209 ECOLAB: PRODUCTS & SERVICES OFFERED
TABLE 210 ECOLAB: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 211 ECOLAB: DEALS
TABLE 212 ECOLAB: OTHERS
11.1.8 BIOM?RIEUX SA
TABLE 213 BIOM?RIEUX SA: COMPANY OVERVIEW
FIGURE 40 BIOM?RIEUX SA: COMPANY SNAPSHOT, 2021
TABLE 214 BIOM?RIEUX SA: PRODUCTS & SERIVCES OFFERED
TABLE 215 BIOM?RIEUX SA: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 216 BIOM?RIEUX SA: DEALS
11.1.9 GOJO INDUSTRIES, INC.
TABLE 217 GOJO INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 218 GOJO INDUSTRIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 219 GOJO INDUSTRIES: PRODUCT LAUNCHES/ENHANCEMENTS
11.1.10 RLDATIX
TABLE 220 RLDATIX: COMPANY OVERVIEW
TABLE 221 RLDATIX: PRODUCTS & SERVICES OFFERED
TABLE 222 RLDATIX: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 223 RLDATIX: DEALS
11.1.11 VIGILANZ CORPORATION
TABLE 224 VIGILANZ CORPORATION: COMPANY OVERVIEW
TABLE 225 VIGILANZ CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 226 VIGILANZ CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS
11.1.12 DEB GROUP LTD
TABLE 227 DEB GROUP LTD.: COMPANY OVERVIEW
TABLE 228 DEB GROUP LTD.: PRODUCTS & SERVICES OFFERED
11.1.13 CLINISYS
TABLE 229 CLINISYS: COMPANY OVERVIEW
TABLE 230 CLINISYS: PRODUCTS & SERVICES OFFERED
TABLE 231 CLINISYS: DEALS
11.1.14 BIOVIGIL HEALTHCARE SYSTEMS
TABLE 232 BIOVIGIL HEALTHCARE SYSTEMS: COMPANY OVERVIEW
TABLE 233 BIOVIGIL HEALTHCARE SYSTEMS: PRODUCTS & SERVICES OFFERED
TABLE 234 BIOVIGIL HEALTHCARE SYSTEMS: DEALS
11.1.15 VECNA TECHNOLOGIES
TABLE 235 VECNA TECHNOLOGIES: COMPANY OVERVIEW
TABLE 236 VECNA TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
11.1.16 HARRIS HEALTHCARE
TABLE 237 HARRIS HEALTHCARE: COMPANY OVERVIEW
TABLE 238 HARRIS HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 239 HARRIS HEALTHCARE: DEALS
11.1.17 PERAHEALTH
TABLE 240 PERAHEALTH: COMPANY OVERVIEW
TABLE 241 PERAHEALTH: PRODUCTS & SERVICES OFFERED
TABLE 242 PERAHEALTH: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 243 PERAHEALTH: DEALS
TABLE 244 PERAHEALTH: OTHERS
11.1.18 MEDEXTER HEALTHCARE
TABLE 245 MEDEXTER HEALTHCARE: COMPANY OVERVIEW
TABLE 246 MEDEXTER HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 247 MEDEXTER HEALTHCARE: PRODUCT LAUNCHES/ENHANCEMENTS
11.1.19 CENTRAK
TABLE 248 CENTRAK: COMPANY OVERVIEW
TABLE 249 CENTRAK: PRODUCTS & SERVICES OFFERED
TABLE 250 CENTRAK: PRODUCT LAUNCHES
TABLE 251 CENTRAK: DEALS
TABLE 252 CENTRAK: OTHERS
11.1.20 CKM HEALTHCARE INCORPORATED
TABLE 253 CKM HEALTHCARE INCORPORATED: COMPANY OVERVIEW
TABLE 254 CKM HEALTHCARE INCORPORATED: PRODUCTS & SERVICES OFFERED
11.2 OTHER PLAYERS
11.2.1 ASOLVA INC.
11.2.2 POINTCLICKCARE
11.2.3 VITALACY INC.
11.2.4 STANLEY HEALTHCARE
11.2.5 VIZZIA TECHNOLOGIES
*Details on Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SEGMENTATION
FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Key insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 9 CAGR PROJECTIONS
FIGURE 10 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION APPROACH
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET
3 EXECUTIVE SUMMARY
FIGURE 12 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 16 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT, 2021
4 PREMIUM INSIGHTS
4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW
FIGURE 17 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY END USER AND COUNTRY
FIGURE 18 HOSPITALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021
4.3 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST REVENUE GROWTH FROM 2022 TO 2027
4.4 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2020–2027)
FIGURE 20 NORTH AMERICA TO DOMINATE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING FORECAST PERIOD
4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing prevalence of hospital-acquired infections
5.2.1.2 Increasing adoption of antimicrobial stewardship programs
5.2.1.3 Increasing number of surgeries
TABLE 4 US: PERCENTAGE INCREASE IN SURGICAL VOLUMES
5.2.1.4 Growing geriatric population and increasing incidence of chronic diseases
5.2.1.5 Growing investments to improve healthcare systems
5.2.2 MARKET RESTRAINTS
5.2.2.1 High cost of deployment for small healthcare organizations
TABLE 5 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2021
5.2.2.2 Reluctance among medical professionals to adopt advanced healthcare IT solutions
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing consolidation in healthcare industry
5.2.3.2 Cloud-based software solutions
5.2.3.3 Emerging markets
5.2.4 MARKET CHALLENGES
5.2.4.1 Shortage of skilled healthcare IT professionals
5.2.4.2 Data security concerns
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 SHIFT TOWARD WEB-BASED SOLUTIONS
6.2.2 AI-POWERED SURVEILLANCE SOFTWARE
6.2.3 SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES
6.2.4 INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS
6.3 REGULATORY ANALYSIS
6.3.1 NORTH AMERICA
TABLE 6 NORTH AMERICA: REGULATIONS AND LAWS
6.3.2 EUROPE
TABLE 7 EUROPE: REGULATIONS AND LAWS
6.3.3 ASIA
TABLE 8 ASIA: REGULATIONS AND LAWS
6.3.4 MIDDLE EAST & AFRICA
TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS AND LAWS
6.3.5 LATIN AMERICA
TABLE 10 LATIN AMERICA: REGULATIONS AND LAWS
TABLE 11 KEY GLOBAL REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS
6.4 TECHNOLOGY ANALYSIS
6.4.1 CLOUD COMPUTING TECHNOLOGY
6.4.2 ARTIFICIAL INTELLIGENCE
TABLE 12 AI IN HEALTHCARE MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 13 AI IN HEALTHCARE MARKET, BY REGION, 2021–2027 (USD MILLION)
6.4.3 BLUETOOTH LOW-ENERGY SENSORS
6.5 ECOSYSTEM ANALYSIS
FIGURE 22 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS
FIGURE 23 INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
6.6 PATENT ANALYSIS
6.6.1 PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2012–JANUARY 2023)
6.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012– JANUARY 2023)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012–JANUARY 2023)
TABLE 14 INFECTION SURVEILLANCE SOLUTIONS: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2022
6.7 IMPACT OF RECESSION
7 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
7.2 SOFTWARE
TABLE 16 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 ON-PREMISE SOFTWARE
7.2.1.1 Data protection and in-house access to HCIT solutions to drive market
TABLE 18 ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 19 ON-PREMISE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 WEB-BASED SOFTWARE
7.2.2.1 Increasing demand for data centralization and cost-benefits of solutions to drive adoption
TABLE 20 WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 21 WEB-BASED SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SERVICES
TABLE 22 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 23 INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 PRODUCT SUPPORT & MAINTENANCE SERVICES
7.3.1.1 Rising reliance on outsourcing HCIT support to boost demand
TABLE 24 PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 TRAINING & CONSULTING SERVICES
7.3.2.1 Need to develop IT infrastructure and demand for expert assistance to offer growth opportunities
TABLE 25 TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 IMPLEMENTATION SERVICES
7.3.3.1 Focus on ensuring regulatory compliance among end users to boost service sector growth
TABLE 26 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
TABLE 28 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 LARGE HOSPITALS
8.2.1.1 Growing need to deploy cloud-based solutions to drive growth
TABLE 30 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 MEDIUM-SIZED HOSPITALS
8.2.2.1 Increasing demand for more specialized and advanced care to boost market
TABLE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.3 SMALL HOSPITALS
8.2.3.1 Need to decrease operational costs and growing competition to support adoption
TABLE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 LONG-TERM CARE FACILITIES
TABLE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.1 NURSING HOMES
8.3.1.1 Growing geriatric population to favor end-user growth
TABLE 35 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.2 SKILLED NURSING FACILITIES
8.3.2.1 Advancements in HCIT solutions to favor adoption in SNFs
TABLE 36 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.3 ASSISTED LIVING FACILITIES
8.3.3.1 ALFs to show significant growth alongside rising geriatric population
TABLE 37 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 OTHER END USERS
TABLE 38 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2020–2027)
TABLE 39 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
FIGURE 28 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
TABLE 40 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.2.2 US
9.2.2.1 Advanced medical infrastructure and increasing healthcare expenditure to drive market growth
TABLE 47 US: KEY MACROINDICATORS
TABLE 48 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 49 US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 52 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Rising adoption of advanced HCIT solutions to propel market growth
TABLE 54 CANADA: KEY MACROINDICATORS
TABLE 55 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 59 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
TABLE 61 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 66 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Germany to hold largest share of European market
TABLE 68 GERMANY: KEY MACROINDICATORS
TABLE 69 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 73 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 High healthcare spending and favorable government initiatives to drive market growth in France
TABLE 75 FRANCE: KEY MACROINDICATORS
TABLE 76 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 80 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.4 UK
9.3.4.1 Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK
TABLE 82 UK: KEY MACROINDICATORS
TABLE 83 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 84 UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 87 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Increasing adoption of eHealth technologies to propel market growth in Italy
TABLE 89 ITALY: KEY MACROINDICATORS
TABLE 90 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 91 ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 94 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Emphasis on infrastructural improvement and rising disease prevalence to contribute to growth
TABLE 96 SPAIN: KEY MACROINDICATORS
TABLE 97 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 98 SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 101 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.7 SWITZERLAND
9.3.7.1 Increasing demand for healthcare services and growing healthcare awareness to augment market
TABLE 103 SWITZERLAND: KEY MACROINDICATORS
TABLE 104 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 105 SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 108 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.8 NETHERLANDS
9.3.8.1 Increasing healthcare initiatives to favor demand growth
TABLE 110 NETHERLANDS: KEY MACROINDICATORS
TABLE 111 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 112 NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 115 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.3.9 REST OF EUROPE
TABLE 117 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 118 ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 121 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
FIGURE 29 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
TABLE 123 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 124 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 128 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Japan to dominate APAC market over forecast period
TABLE 130 JAPAN: KEY MACROINDICATORS
TABLE 131 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 135 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Healthcare infrastructure improvements in China to contribute to market growth
TABLE 137 CHINA: KEY MACROINDICATORS
TABLE 138 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 139 CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 142 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing demand for HCIT solutions to support market growth
TABLE 144 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 145 INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 148 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.5 AUSTRALIA AND NEW ZEALAND
9.4.5.1 Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ
TABLE 150 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 151 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 154 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Increasing medical tourism to boost market
TABLE 156 SOUTH KOREA: KEY MACROINDICATORS
TABLE 157 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 158 SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 161 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 163 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 164 ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 167 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 FAVORABLE HCIT INITIATIVES TO DRIVE MARKET GROWTH
9.5.2 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
TABLE 169 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH
9.6.2 MIDDLE EAST AND AFRICA: IMPACT OF ECONOMIC RECESSION
TABLE 175 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
10.3 ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS
10.4 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS
10.5 MARKET SHARE ANALYSIS
FIGURE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET: MARKET SHARE ANALYSIS, 2021
10.6 COMPETITIVE BENCHMARKING
TABLE 181 COMPANY FOOTPRINT ANALYSIS
TABLE 182 PRODUCT & SERVICE FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 183 END-USER FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 184 REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES)
10.7 COMPANY EVALUATION QUADRANT, 2021
10.7.1 STARS
10.7.2 PERVASIVE PLAYERS
10.7.3 EMERGING LEADERS
10.7.4 PARTICIPANTS
FIGURE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2021
10.8 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
10.8.1 PROGRESSIVE COMPANIES
10.8.2 DYNAMIC COMPANIES
10.8.3 RESPONSIVE COMPANIES
10.8.4 STARTING BLOCKS
FIGURE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS
TABLE 185 INFECTION SURVEILLANCE SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS, 2020–2022
10.9.2 DEALS
TABLE 186 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEALS, 2020–2022
10.9.3 OTHER DEVELOPMENTS
TABLE 187 INFECTION SURVEILLANCE SOLUTIONS MARKET: OTHER DEVELOPMENTS, 2020–2022
11 COMPANY PROFILES
(Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 BECTON, DICKINSON AND COMPANY
TABLE 188 BD: COMPANY OVERVIEW
FIGURE 34 BD: COMPANY SNAPSHOT, 2022
TABLE 189 BD: PRODUCTS & SERVICES OFFERED
TABLE 190 BD: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 191 BD: DEALS
11.1.2 CERNER CORPORATION
TABLE 192 CERNER CORPORATION: COMPANY OVERVIEW
FIGURE 35 CERNER CORPORATION: COMPANY SNAPSHOT, 2021
TABLE 193 CERNER CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 194 CERNER CORPORATION: DEALS
11.1.3 PREMIER, INC.
TABLE 195 PREMIER, INC.: COMPANY OVERVIEW
FIGURE 36 PREMIER, INC.: COMPANY SNAPSHOT, 2022
TABLE 196 PREMIER, INC.: PRODUCTS & SERVICES OFFERED
TABLE 197 PREMIER, INC.: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 198 PREMIER, INC.: DEALS
11.1.4 BAXTER INTERNATIONAL INC.
TABLE 199 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW
FIGURE 37 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT, 2021
TABLE 200 BAXTER INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
11.1.5 WOLTERS KLUWER N.V.
TABLE 201 WOLTERS KLUWER N.V.: COMPANY OVERVIEW
FIGURE 38 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT, 2021
TABLE 202 WOLTERS KLUWER N.V.: PRODUCTS & SERVICES OFFERED
TABLE 203 WOLTERS KLUWER N.V.: LAUNCHES/ENHANCEMENTS
TABLE 204 WOLTERS KLUWER N.V.: OTHERS
11.1.6 MERATIVE
TABLE 205 MERATIVE: COMPANY OVERVIEW
TABLE 206 MERATIVE: PRODUCTS & SERVICES OFFERED
TABLE 207 MERATIVE: OTHERS
11.1.7 ECOLAB
TABLE 208 ECOLAB: COMPANY OVERVIEW
FIGURE 39 ECOLAB: COMPANY SNAPSHOT, 2021
TABLE 209 ECOLAB: PRODUCTS & SERVICES OFFERED
TABLE 210 ECOLAB: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 211 ECOLAB: DEALS
TABLE 212 ECOLAB: OTHERS
11.1.8 BIOM?RIEUX SA
TABLE 213 BIOM?RIEUX SA: COMPANY OVERVIEW
FIGURE 40 BIOM?RIEUX SA: COMPANY SNAPSHOT, 2021
TABLE 214 BIOM?RIEUX SA: PRODUCTS & SERIVCES OFFERED
TABLE 215 BIOM?RIEUX SA: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 216 BIOM?RIEUX SA: DEALS
11.1.9 GOJO INDUSTRIES, INC.
TABLE 217 GOJO INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 218 GOJO INDUSTRIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 219 GOJO INDUSTRIES: PRODUCT LAUNCHES/ENHANCEMENTS
11.1.10 RLDATIX
TABLE 220 RLDATIX: COMPANY OVERVIEW
TABLE 221 RLDATIX: PRODUCTS & SERVICES OFFERED
TABLE 222 RLDATIX: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 223 RLDATIX: DEALS
11.1.11 VIGILANZ CORPORATION
TABLE 224 VIGILANZ CORPORATION: COMPANY OVERVIEW
TABLE 225 VIGILANZ CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 226 VIGILANZ CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS
11.1.12 DEB GROUP LTD
TABLE 227 DEB GROUP LTD.: COMPANY OVERVIEW
TABLE 228 DEB GROUP LTD.: PRODUCTS & SERVICES OFFERED
11.1.13 CLINISYS
TABLE 229 CLINISYS: COMPANY OVERVIEW
TABLE 230 CLINISYS: PRODUCTS & SERVICES OFFERED
TABLE 231 CLINISYS: DEALS
11.1.14 BIOVIGIL HEALTHCARE SYSTEMS
TABLE 232 BIOVIGIL HEALTHCARE SYSTEMS: COMPANY OVERVIEW
TABLE 233 BIOVIGIL HEALTHCARE SYSTEMS: PRODUCTS & SERVICES OFFERED
TABLE 234 BIOVIGIL HEALTHCARE SYSTEMS: DEALS
11.1.15 VECNA TECHNOLOGIES
TABLE 235 VECNA TECHNOLOGIES: COMPANY OVERVIEW
TABLE 236 VECNA TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
11.1.16 HARRIS HEALTHCARE
TABLE 237 HARRIS HEALTHCARE: COMPANY OVERVIEW
TABLE 238 HARRIS HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 239 HARRIS HEALTHCARE: DEALS
11.1.17 PERAHEALTH
TABLE 240 PERAHEALTH: COMPANY OVERVIEW
TABLE 241 PERAHEALTH: PRODUCTS & SERVICES OFFERED
TABLE 242 PERAHEALTH: PRODUCT LAUNCHES/ENHANCEMENTS
TABLE 243 PERAHEALTH: DEALS
TABLE 244 PERAHEALTH: OTHERS
11.1.18 MEDEXTER HEALTHCARE
TABLE 245 MEDEXTER HEALTHCARE: COMPANY OVERVIEW
TABLE 246 MEDEXTER HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 247 MEDEXTER HEALTHCARE: PRODUCT LAUNCHES/ENHANCEMENTS
11.1.19 CENTRAK
TABLE 248 CENTRAK: COMPANY OVERVIEW
TABLE 249 CENTRAK: PRODUCTS & SERVICES OFFERED
TABLE 250 CENTRAK: PRODUCT LAUNCHES
TABLE 251 CENTRAK: DEALS
TABLE 252 CENTRAK: OTHERS
11.1.20 CKM HEALTHCARE INCORPORATED
TABLE 253 CKM HEALTHCARE INCORPORATED: COMPANY OVERVIEW
TABLE 254 CKM HEALTHCARE INCORPORATED: PRODUCTS & SERVICES OFFERED
11.2 OTHER PLAYERS
11.2.1 ASOLVA INC.
11.2.2 POINTCLICKCARE
11.2.3 VITALACY INC.
11.2.4 STANLEY HEALTHCARE
11.2.5 VIZZIA TECHNOLOGIES
*Details on Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
